Literature DB >> 32766755

Inflammatory Bowel Disease-Associated Changes in the Gut: Focus on Kazan Patients.

Giuseppe Lo Sasso1, Lusine Khachatryan1, Athanasios Kondylis1, James N D Battey1, Nicolas Sierro1, Natalia A Danilova2, Tatiana V Grigoryeva2, Maria I Markelova2, Dilyara R Khusnutdinova2, Alexander V Laikov2, Ilnur I Salafutdinov2, Yulia D Romanova2, Mariia N Siniagina2, Ilya Yu Vasiliev2, Eugenia A Boulygina2, Valeriya V Solovyeva2, Ekaterina E Garanina2, Kristina V Kitaeva2, Konstantin Y Ivanov2, Darja S Chulpanova2, Konstantin S Kletenkov2, Alina R Valeeva3, Alfiya Kh Odintsova4, Maria D Ardatskaya5, Rustam A Abdulkhakov3, Nikolai V Ivanov1, Manuel C Peitsch1, Julia Hoeng1, Sayar R Abdulkhakov2.   

Abstract

BACKGROUND: Several studies have highlighted the role of host-microbiome interactions in the pathogenesis of inflammatory bowel disease (IBD), resulting in an increasing amount of data mainly focusing on Western patients. Because of the increasing prevalence of IBD in newly industrialized countries such as those in Asia, the Middle East, and South America, there is mounting interest in elucidating the gut microbiota of these populations. We present a comprehensive analysis of several IBD-related biomarkers and gut microbiota profiles and functions of a unique population of patients with IBD and healthy patients from Kazan (Republic of Tatarstan, Russia).
METHODS: Blood and fecal IBD biomarkers, serum cytokines, and fecal short-chain fatty acid (SCFA) content were profiled. Finally, fecal microbiota composition was analyzed by 16S and whole-genome shotgun sequencing.
RESULTS: Fecal microbiota whole-genome sequencing confirmed the presence of classic IBD dysbiotic features at the phylum level, with increased abundance of Proteobacteria, Actinobacteria, and Fusobacteria and decreased abundance of Firmicutes, Bacteroidetes, and Verrucomicrobia. At the genus level, the abundance of both fermentative (SCFA-producing and hydrogen (H2)-releasing) and hydrogenotrophic (H2-consuming) microbes was affected in patients with IBD. This imbalance was confirmed by the decreased abundance of SCFA species in the feces of patients with IBD and the change in anaerobic index, which mirrors the redox status of the intestine.
CONCLUSIONS: Our analyses highlighted how IBD-related dysbiotic microbiota-which are generally mainly linked to SCFA imbalance-may affect other important metabolic pathways, such as H2 metabolism, that are critical for host physiology and disease development.
© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.

Entities:  

Keywords:  inflammatory bowel disease; microbial dysbiosis; short-chain fatty acids

Mesh:

Substances:

Year:  2021        PMID: 32766755      PMCID: PMC7885336          DOI: 10.1093/ibd/izaa188

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  41 in total

Review 1.  Existing dietary guidelines for Crohn's disease and ulcerative colitis.

Authors:  Amy C Brown; S Devi Rampertab; Gerard E Mullin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 3.869

2.  Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.

Authors:  N A Danilova; S R Abdulkhakov; T V Grigoryeva; M I Markelova; I Yu Vasilyev; E A Boulygina; M D Ardatskaya; A V Pavlenko; A V Tyakht; A Kh Odintsova; R A Abdulkhakov
Journal:  Ter Arkh       Date:  2019-05-15       Impact factor: 0.467

Review 3.  Evolving Epidemiology of IBD.

Authors:  Joseph W Windsor; Gilaad G Kaplan
Journal:  Curr Gastroenterol Rep       Date:  2019-07-23

4.  Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.

Authors:  Wei Wang; Liping Chen; Rui Zhou; Xiaobing Wang; Lu Song; Sha Huang; Ge Wang; Bing Xia
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

5.  Valerate production by Megasphaera elsdenii isolated from pig feces.

Authors:  Shota Yoshikawa; Ryosuke Araoka; Yu Kajihara; Toshiyuki Ito; Hirokuni Miyamoto; Hiroaki Kodama
Journal:  J Biosci Bioeng       Date:  2018-01-11       Impact factor: 2.894

6.  A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.

Authors:  S Matsumoto; T Hara; M Nagaoka; A Mike; K Mitsuyama; T Sako; M Yamamoto; S Kado; T Takada
Journal:  Immunology       Date:  2008-10-15       Impact factor: 7.397

7.  Unlocking the potential of metagenomics through replicated experimental design.

Authors:  Rob Knight; Janet Jansson; Dawn Field; Noah Fierer; Narayan Desai; Jed A Fuhrman; Phil Hugenholtz; Daniel van der Lelie; Folker Meyer; Rick Stevens; Mark J Bailey; Jeffrey I Gordon; George A Kowalchuk; Jack A Gilbert
Journal:  Nat Biotechnol       Date:  2012-06-07       Impact factor: 54.908

8.  Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.

Authors:  Kelly A Shaw; Madeline Bertha; Tatyana Hofmekler; Pankaj Chopra; Tommi Vatanen; Abhiram Srivatsa; Jarod Prince; Archana Kumar; Cary Sauer; Michael E Zwick; Glen A Satten; Aleksandar D Kostic; Jennifer G Mulle; Ramnik J Xavier; Subra Kugathasan
Journal:  Genome Med       Date:  2016-07-13       Impact factor: 11.117

Review 9.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.

Authors:  Ramnik J Xavier; Curtis Huttenhower; Jason Lloyd-Price; Cesar Arze; Ashwin N Ananthakrishnan; Melanie Schirmer; Julian Avila-Pacheco; Tiffany W Poon; Elizabeth Andrews; Nadim J Ajami; Kevin S Bonham; Colin J Brislawn; David Casero; Holly Courtney; Antonio Gonzalez; Thomas G Graeber; A Brantley Hall; Kathleen Lake; Carol J Landers; Himel Mallick; Damian R Plichta; Mahadev Prasad; Gholamali Rahnavard; Jenny Sauk; Dmitry Shungin; Yoshiki Vázquez-Baeza; Richard A White; Jonathan Braun; Lee A Denson; Janet K Jansson; Rob Knight; Subra Kugathasan; Dermot P B McGovern; Joseph F Petrosino; Thaddeus S Stappenbeck; Harland S Winter; Clary B Clish; Eric A Franzosa; Hera Vlamakis
Journal:  Nature       Date:  2019-05-29       Impact factor: 49.962

10.  Human gut microbiota community structures in urban and rural populations in Russia.

Authors:  Alexander V Tyakht; Elena S Kostryukova; Anna S Popenko; Maxim S Belenikin; Alexander V Pavlenko; Andrey K Larin; Irina Y Karpova; Oksana V Selezneva; Tatyana A Semashko; Elena A Ospanova; Vladislav V Babenko; Igor V Maev; Sergey V Cheremushkin; Yuriy A Kucheryavyy; Petr L Shcherbakov; Vladimir B Grinevich; Oleg I Efimov; Evgenii I Sas; Rustam A Abdulkhakov; Sayar R Abdulkhakov; Elena A Lyalyukova; Maria A Livzan; Valentin V Vlassov; Renad Z Sagdeev; Vladislav V Tsukanov; Marina F Osipenko; Irina V Kozlova; Alexander V Tkachev; Valery I Sergienko; Dmitry G Alexeev; Vadim M Govorun
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  6 in total

Review 1.  Regulatory role of short-chain fatty acids in inflammatory bowel disease.

Authors:  Zhilin Zhang; Huan Zhang; Tian Chen; Lin Shi; Daorong Wang; Dong Tang
Journal:  Cell Commun Signal       Date:  2022-05-11       Impact factor: 7.525

Review 2.  Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease.

Authors:  Laila Aldars-García; María Chaparro; Javier P Gisbert
Journal:  Microorganisms       Date:  2021-04-30

3.  Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.

Authors:  Ilnar F Shaidullov; Dina M Sorokina; Farit G Sitdikov; Anton Hermann; Sayar R Abdulkhakov; Guzel F Sitdikova
Journal:  BMC Gastroenterol       Date:  2021-01-26       Impact factor: 3.067

Review 4.  Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.

Authors:  Elena Layunta; Berta Buey; Jose Emilio Mesonero; Eva Latorre
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

5.  Diversity and Adaptations of Escherichia coli Strains: Exploring the Intestinal Community in Crohn's Disease Patients and Healthy Individuals.

Authors:  Maria N Siniagina; Maria I Markelova; Eugenia A Boulygina; Alexander V Laikov; Dilyara R Khusnutdinova; Sayar R Abdulkhakov; Natalia A Danilova; Alfiya H Odintsova; Rustam A Abdulkhakov; Tatyana V Grigoryeva
Journal:  Microorganisms       Date:  2021-06-15

Review 6.  The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.

Authors:  Laila Aldars-García; Alicia C Marin; María Chaparro; Javier P Gisbert
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.